OSM signaling and the associated repression of IFN-β results in an increased tumor sphere frequency in vitro (Fig. 3d), increased tumor-forming capability in vivo (Fig. 3e), and increased migration (Fig. 3f). Here, IFNB1 is linked to neoplasm.